iNKT cells had not previously been examined in CFS/ME and the current study found expression of CD62L was significantly increased in moderate CFS/ME patients between 0 and 6 months. The gene discussed is SELL; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.